CSET researchers share their early analysis of the White House's AI Policy Framework and what the prospects are for near-term legislative action on AI.

The barriers to bioattacks are hard to identify — and it's even harder to know whether AI is reducing them

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This three-part series introduces CSET’s patent clusters, which connect related patents throu...

In response to the Office of Science and Technology Policy's request for input on an AI Action Plan, CSET provides key recommendations for advancing AI research, ensuring U.S. competitiveness, and max...

The companies that sell synthesized DNA to scientists need to screen their customers, lest dangerous sequences for pathogens or toxins fall into the wrong hands.

On Tuesday, scientists held an event organized by House Democrats in which they stood in front of posters outlining their work — and the federal cuts that now threaten it.

It comes as another guidance was set to take effect

The rising death toll for a preventable disease reveals just how ill-prepared the country is to handle a malicious bioweapon.

The companies that sell synthesized DNA to scientists need to screen their customers, lest dangerous sequences for pathogens or toxins fall into the wrong hands.

TO THE AMERICAN PEOPLE We all rely on science. Science gave us the smartphones in our pockets, the navigation systems in our cars, and life-saving medical care. We count on engineers when we drive acr...

Investing in scientific research and development is vital to U.S. security.

As China challenges, NIH and NSF funds play a key role in U.S. research efforts

Dr. Steph Batalis and Vikram Venkatram offered the following comment in response to the National Institute of Standards and Technology's request for information on safety considerations for chemical a...